Related Experiment Video
Updated: Aug 8, 2025

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
Expanding the clinical phenotype of nuclear matrix protein 2 antibody-positive dermatomyositis
Michelle Toker1, Roya S Nazarian1, Pooja Srivastava2
1Division of Dermatology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
No abstract available in PubMed .
More Related Videos
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
10:05Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
Published on: January 17, 2018
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Nephrotic Syndrome I : Introduction
Myocarditis I: Introduction
Chronic Kidney Disease II: Clinical Manifestations